When leukemia relapses after chemotherapy, many patients and families fear their options have run out. The reality is more hopeful: advanced treatments including CAR-T cell therapy, stem cell transplants, and immunotherapies can deliver remission even after standard regimens fail. Key Takeaways Treatment options remain available when leukemia relapses after chemotherapy, CAR-T cell therapy is FDA-approved for B-cell ALL and CLL, while allogeneic stem cell transplant addresses

When leukemia returns after chemotherapy, patients face difficult questions about next steps. Multiple treatment pathways exist, including reinduction chemotherapy, CAR-T cell therapy, allogeneic stem cell transplantation, and clinical trials. Eligibility depends on relapse timing, blast count, CD19 expression, and prior transplant status. Understanding these factors helps patients and families navigate treatment sequencing decisions. Key Takeaways Early relapse (<12 months)